Opinion
MedPage Today on MSNOpinion
A Journal Promised to Retract a Flawed Autism Study. It's Still Online.
Katie Suleta, DHSc, MPH, MS, is a public health expert specializing in epidemiology and informatics, with a focus on infectious diseases, graduate medical education, and Medicaid data. She is a writer ...
Results published in AAST’s Trauma Surgery & Acute Care Open Journal -- Study compared outcomes of patients treated with Symvess with ...
Incyte today announced that data from key programs in its oncology portfolio will be presented in both oral and poster sessions at the 2025 American Society of Hematology (ASH) Annual Meeting, to be ...
"The results of this study may be highly impactful in our major markets including the U.S. and Europe." The objective of the independent retrospective observational study ... of the Company's Annual ...
Introduction Chronic kidney disease (CKD) affects 1 in 10 people worldwide and can progress towards kidney failure, which is ...
Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today ...
PetPace, the leading provider of smart wearable health monitoring collars for animals and Crucial Data Solutions, Inc. (CDS), the pioneer behind the end-to-end eClinical platform TrialKit, today ...
With road infrastructure steadily expanding—and projections indicating significant growth—it is important to ensure that road construction and upgrades do not trigger direct and indirect biodiversity ...
Cardiometabolic diseases, including cardiovascular disease, type 2 diabetes, obesity, and metabolic syndrome, represent a growing global health burden, ...
An underwater robot called Lassie has discovered "remarkable" icefish nests while searching for Sir Ernest Shackleton’s lost ...
Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR ...
"These results are encouraging, highlighting TET2-mutated clonal hematopoiesis as a potential biomarker to select patients who are more likely to respond to immunotherapy," said Padmanee Sharma, M.D., ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results